SG
BRTX icon

StoneX Group’s BioRestorative Therapies BRTX Stock Holding History

StoneX Group’s Portfolio BRTX Stock Details BRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.23K Buy
+695
New +$4.07K ﹤0.01% 1412
2025
Q4 		– Sell
-1,873
Closed -$54.3K – 1101
2025
Q3 		$54.3K Sell
1,873
-14
-0.7% -$433 ﹤0.01% 866
2025
Q2 		$62.9K Sell
1,887
-673
-26% -$23.4K ﹤0.01% 815
2025
Q1 		$91.1K Buy
2,560
+53
+2% +$2.03K 0.01% 805
2024
Q4 		$71.7K Sell
2,507
-119
-5% -$3.68K ﹤0.01% 780
2024
Q3 		$91.4K Sell
2,626
-220
-8% -$7.25K 0.01% 595
2024
Q2 		$116K Buy
2,846
+1,103
+63% +$31.8K 0.01% 581
2024
Q1 		$48.1K Buy
1,743
+549
+46% +$16.9K ﹤0.01% 565
2023
Q4 		$41.5K Hold
1,194
– – ﹤0.01% 555
2023
Q3 		$42.7K Buy
1,194
+450
+60% +$22.7K ﹤0.01% 575
2023
Q2 		$65.6K Sell
744
-4
-0.5% -$383 0.01% 554
2023
Q1 		$50.8K Sell
748
-169
-18% -$10.4K 0.01% 581
2022
Q4 		$50.4K Buy
917
+169
+23% +$10.5K 0.01% 525
2022
Q3 		$48.3K Hold
748
– – 0.01% 482
2022
Q2 		$44.1K Hold
748
– – 0.01% 615
2022
Q1 		$78.2K Hold
748
– – 0.01% 599
2021
Q4 		$64.9K Buy
+748
New +$85.4K 0.01% 546

Other funds holding BRTX

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XTX Topco
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.2B AUM 26.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KFGK
Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return

StoneX Group's BRTX Position: Q2 2026 in Review

StoneX Group opened a new position in BioRestorative Therapies (BRTX) in Q2 2026: 695 shares worth $5.23K. The stake represents ﹤0.01% of the portfolio and ranks #1412 among its holdings. This is a return to the name: StoneX Group previously reported a position in BRTX as recently as Q3 2025.

StoneX Group first reported a position in BRTX in Q4 2021 and has held it in 17 quarters since. The position peaked at $116K in Q2 2024. 18 funds tracked by Wall St. Rank hold BRTX as of Q2 2026.

  • StoneX Group held 695 shares of BioRestorative Therapies worth $5.23K as of Q2 2026.
  • BioRestorative Therapies was a new StoneX Group position in Q2 2026.
  • BioRestorative Therapies made up ﹤0.01% of StoneX Group's portfolio in Q2 2026, its #1412 holding.
  • StoneX Group first reported a position in BioRestorative Therapies in Q4 2021 and has held it in 17 quarters since.
  • StoneX Group's BioRestorative Therapies position peaked at $116K in Q2 2024.
  • 18 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.